Christopher G. Salib

Christopher G. Salib

Auto-generated profile, based on publicly available information

Christopher G. Salib

Department of Orthopedic Surgery, Mayo Clinic, Rochester, Minnesota

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
17 July 2019 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MTMeagan E. Tibbo
Meagan E. Tibbo
ALAfton Limberg
Afton Limberg
CSChristopher G. Salib
Christopher G. Salib
AAAhmed T. Ahmed
Ahmed T. Ahmed
Andre J. van WijnenAndre J. van Wijnen
Andre J. van Wijnen
MAMatthew P. Abdel
Matthew P. Abdel
Background: Stiffness is a common reason for suboptimal clinical outcomes after primary total knee arthroplasty (pTKA). There is a lack of consensus regarding its definition, which is often conflated with its histopathologic subcategory—i.e., arthrofibrosis. There is value in refining the definition of acquired idiopathic stiffness in an effort to select for patients with arthrofibrosis. We conducted a systematic review and meta-analysis to establish a consensus definition of acquired idiopathic stiffness, determine its prevalence after pTKA, and identify potential risk factors for its development.Methods: MEDLINE, Embase, Cochrane Controlled Register of Trials (CENTRAL), and Scopus databases were searched from 2002 to 2017. Studies that included patients with stiffness after pTKA were screened with strict inclusion and exclusion criteria to isolate the subset of patients with acquired idiopathic stiffness unrelated to known extrinsic or surgical causes. Three authors independently assessed study eligibility and risk of bias and collected data. Outcomes of interest were then analyzed according to age, sex, and body mass index (BMI).Results: In the 35 included studies (48,873 pTKAs), the mean patient age was 66 years. In 63% of the studies, stiffness was defined as a range of motion of 5° at 6 to 12 weeks postoperatively. The prevalence of acquired idiopathic stiffness after pTKA was 4%, and this did not differ according to age (4%, I2= 95%, among patients <65 years old and 5%, I2= 96%, among those ≥65 years old; p = 0.238). The prevalence of acquired idiopathic stiffness was significantly lower in males (1%, I2= 85%) than females (3%, I2= 95%) (p < 0.0001) as well as in patients with a BMI of <30 kg/m2(2%, I2= 94%) compared with those with a BMI of ≥30 kg/m2(5%, I2= 97%) (p = 0.027).Conclusions: Contemporary literature supports the following definition for acquired idiopathic stiffness: a range of motion of 12 weeks after pTKA in patients in the absence of complicating factors including preexisting stiffness. The mean prevalence of acquired idiopathic stiffness after pTKA was 4%; females and obese patients were at increased risk.Level of Evidence: TherapeuticLevel IV. See Instructions for Authors for a complete description of levels of evidence.

1 August 2018 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
MAMatthew P. Abdel
Matthew P. Abdel
CSChristopher G. Salib
Christopher G. Salib
KMKristin C. Mara
Kristin C. Mara
MPMark W. Pagnano
Mark W. Pagnano
KPKevin I. Perry
Kevin I. Perry
AHArlen D. Hanssen
Arlen D. Hanssen
Background: Disruption of the extensor mechanism after total knee arthroplasty (TKA) is debilitating, and the reported results of numerous reconstructive options have varied. We previously reported the early results of 13 patients who underwent reconstruction of the extensor mechanism with use of Marlex mesh. The purpose of the current study was to assess results in a larger cohort of patients, with an emphasis on the survivorship of the mesh, clinical results, and complications.Methods: During the period of 2000 to 2015 at a single tertiary care academic institution, 77 patients (77 TKAs) underwent reconstruction with use of Marlex mesh for an extensor mechanism disruption (27 quadriceps tendon disruptions, 40 patellar tendon disruptions, and 10 patellar fractures). The mean patient age at the time of reconstruction was 65 years; 70% of the patients were female. The mean body mass index was 35 kg/m2. The mean follow-up was 4 years. Eighteen (23%) of the patients underwent mesh reconstruction with the primary TKA in place, and 59 (77%) had mesh reconstruction at the time of revision TKA. The mean time between disruption and reconstruction was 7 months. Twenty (26%) of the patients had previously undergone attempted extensor mechanism reconstruction at outside institutions.Results: Sixty-five of the 77 mesh reconstructions were in place at the time of the latest follow-up. Twelve patients experienced a failure that required mesh revision: 5 for patellar tendon rupture, 5 for quadriceps tendon rupture, and 2 for symptomatic lengthening. Four additional patients with mesh failure were treated nonoperatively with bracing. The 2-year survivorship free of mesh revision was 86% for patients with no prior reconstruction and 95% for patients with previous reconstructions of the extensor mechanism that did not involve Marlex mesh. Knee Society Score (KSS) results significantly improved following reconstruction (p < 0.001). Extensor lag improved by a mean of 26°, with mean postoperative extensor lag measuring 9° (p < 0.001).Conclusions: Reconstruction of the extensor mechanism with use of Marlex mesh is a viable option in patients with catastrophic disruption after TKA. At the time of the latest follow-up, 84% of the mesh reconstructions were in place and the functional outcomes were excellent, with mean improvement in extensor lag of 26°. Extended follow-up is required, but the results of this large series with a mean follow-up of 4 years are encouraging.Level of Evidence: TherapeuticLevel IV. See Instructions for Authors for a complete description of levels of evidence.

1 August 2020 in JBJS Reviews
Verified
Journal Article
Closed access
JBJoshua S. Bingham
Joshua S. Bingham
CSChristopher G. Salib
Christopher G. Salib
AHArlen D. Hanssen
Arlen D. Hanssen
MTMichael J. Taunton
Michael J. Taunton
MPMark W. Pagnano
Mark W. Pagnano
MAMatthew P. Abdel
Matthew P. Abdel
Background: Total knee arthroplasties (TKAs) with cementless fixation have been studied in multiple series with varying success. The aim of this study was to prepare a systematic review of the literature to evaluate clinical outcomes and revtpdelision rates of patients undergoing contemporary cementless TKA. Methods: A search of PubMed and MEDLINE was conducted for English-language articles published between 2005 and 2018 to identify studies examining survivorship and clinical outcomes of cementless TKAs. Studies that reported clinical and/or radiographic outcomes were included. Data collected included the number of TKAs, implant utilized, primary diagnosis, mean age and follow-up, implant survivorship, complications, revisions, and clinical outcome scores. All hybrid constructs and revision TKAs were excluded. Poisson regression analysis was used to determine the revision incidence rates per 1,000 person-years. Results: Forty-three studies with 10,447 TKAs met inclusion criteria, of which 8,187 were primary cementless TKAs. The mean follow-up was 7 years. The revision incidence per 1,000 person-years was 4.8 for all cementless designs. The complication rate for all cementless TKAs was 6%, with deep venous thrombosis being the most common complication. The mean postoperative Knee Society Score and Functional Score were 92 and 83, respectively. Conclusions: While newer-generation cementless designs have shown improved survivorship and clinical outcomes compared with earlier-generation cementless designs, the literature for cementless designs remains limited when compared with cemented designs. Further studies are needed to determine if cementless TKA can achieve the same benefits that have been realized with cementless total hip arthroplasty. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

5 September 2018 in Journal of Bone and Joint Surgery
Verified
Journal Article
Closed access
KPKevin I. Perry
Kevin I. Perry
CSChristopher G. Salib
Christopher G. Salib
DLDirk R. Larson
Dirk R. Larson
MPMark W. Pagnano
Mark W. Pagnano
MAMatthew P. Abdel
Matthew P. Abdel
AHArlen D. Hanssen
Arlen D. Hanssen
Background: Periprosthetic joint infection (PJI) of the knee with concurrent disruption of the extensor mechanism is a devastating complication. Historically, knees with such complications have been salvaged with use of an arthrodesis or amputation. The purpose of this study was to assess the survival and functional outcomes of a 2-stage exchange arthroplasty combined with knitted monofilament polypropylene (Marlex; C.R. Bard) mesh reconstruction of the extensor mechanism. Methods: From 2000 to 2015, 16 patients underwent a 2-stage exchange arthroplasty and Marlex-mesh reconstruction for PJI with an extensor mechanism disruption. The study included 9 male patients and 7 female patients with a mean age at the time of reimplantation and mesh reconstruction of 64 years. The mean follow-up was 4 years. PJI was diagnosed on the basis of the Musculoskeletal Infection Society criteria. Clinical outcomes, including survivorship, Knee Society Score (KSS) results, and complications, were assessed. Results: Of 16 reconstructions, 13 were in place at the time of the latest follow-up. At 2 years, survivorship free of mesh failure was 86%, survivorship free of PJI was 87%, and survivorship free of PJI or mesh failure was 75%. The mean KSS improved from 48 prior to resection to 74 after mesh reconstruction and reimplantation. The mean extensor lag improved from 31° prior to resection to 3° after mesh reconstruction. Two patients required mesh revision, 1 patient required an above-the-knee amputation for complex wound complications related to reinfection, 1 patient developed a reinfection requiring irrigation and debridement, and 1 patient developed a superficial infection that required debridement. Conclusions: Two-stage exchange arthroplasty combined with Marlex-mesh reconstruction of the extensor mechanism is a viable alternative to knee arthrodesis or amputation. At 2 years, 75% of mesh reconstructions were in place and without evidence of PJI. Moreover, the functional outcomes were improved, with a negligible extensor lag. Level of Evidence: Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.

1 December 2019 in Genomics
Verified
Journal Article
Closed access
CSChristopher G. Salib
Christopher G. Salib
ELEric A. Lewallen
Eric A. Lewallen
CPChristopher R. Paradise
Christopher R. Paradise
MTMeagan E. Tibbo
Meagan E. Tibbo
JRJoseph X. Robin
Joseph X. Robin
MAMatthew P. Abdel
Matthew P. Abdel

1 September 2018 in Genomics
Verified
Journal Article
Closed access
ELEric A. Lewallen
Eric A. Lewallen
CSChristopher G. Salib
Christopher G. Salib
WTWilliam H. Trousdale
William H. Trousdale
CBCharlotte E. Berry
Charlotte E. Berry
GHGabrielle M. Hanssen
Gabrielle M. Hanssen
MAMatthew P. Abdel
Matthew P. Abdel